CereVasc, Inc. announced it has completed the initial closing of an $85 million Series C financing. The clinical-stage ...
Advanced NanoTherapies, Inc. (ANT), which is developing the SirPlux Duo drug-coated balloon therapy for coronary and ...
The Society of Interventional Radiology (SIR) published a new practice guidance on prostate artery embolization (PAE) for the ...
Mentice AB announced a comarketing agreement with Siemens Healthineers to allow clinicians access to the Mentice Ankyras clinical d ...
Cercare Receives FDA Clearance for CBCT Perfusion and Collaborates With Siemens on Acute Stroke Care
Cercare Medical, a developer of neuroimaging software, announced FDA 510(k) clearance for the company’s Cone-Beam CT Perfusio ...
Arsenal Medical announced that the FDA granted investigational device exemption approval for the RADIANT pivotal trial. The ...
Amplifi Vascular announced the initiation of the AMPLIFI-1 pivotal trial evaluating the safety and effectiveness of the Amplifi vei ...
Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced the publication of results from the RAGE study of ...
Rationale for use of optical coherence tomography during BTK intervention, procedural steps, limitations, and future considerations.
Ms. Pouncey discusses the WARRIORS trial of EVAR in women with small AAAs, her health equity–focused research approach, fully automated volume segmentation for AAA assessment, and cultural challenges ...
Calcified femoropopliteal arterial disease remains a major challenge in endovascular therapy. Vessel preparation technologies have emerged to improve ...
J&J obtains CE Mark approval for the Cereglide 42 and Cereglide 57 aspiration catheters. CE Mark also granted for the Cereglide 71 aspiration system, combining the Cereglide 71 aspiration catheter and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results